New sleep disorder drug ORX750 tested for Long-Term safety
NCT ID NCT07096674
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is a long-term follow-up for people with narcolepsy or idiopathic hypersomnia who previously took the experimental drug ORX750. Researchers want to see if the drug remains safe and effective over time. About 90 participants will take ORX750 orally and be monitored for side effects and symptom control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ORX750 (oral drug)
What this could lead to
If successful, this could provide a long-term treatment option to help manage excessive daytime sleepiness and improve daily functioning for people with narcolepsy or idiopathic hypersomnia.
What could go wrong
This is an early-phase, open-label extension study with no placebo group, so results may not confirm effectiveness. Side effects or lack of sustained benefit could limit its use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Abington, Pennsylvania
RECRUITINGAbington, Pennsylvania, 19046, United States
-
Atlanta, Georgia
RECRUITINGAtlanta, Georgia, 30328, United States
-
Auburn, alabama
RECRUITINGAuburn, Alabama, 36832, United States
-
Austin, Texas
RECRUITINGAustin, Texas, 30328, United States
-
Bologna
RECRUITINGBologna, BO, 40139, Italy
-
Cincinnati, Ohio
RECRUITINGCincinnati, Ohio, 45245, United States
-
Denver, North Carolina
RECRUITINGDenver, North Carolina, 28037, United States
-
Dublin
RECRUITINGDublin, Ohio, 43017, United States
-
El Paso, Texas
RECRUITINGEl Paso, Texas, 79912, United States
-
Hendersen, Navada
RECRUITINGHenderson, Nevada, 89052, United States
-
Henderson, Nevada
RECRUITINGHenderson, Nevada, 89052, United States
-
Huntersville, North Carolina
RECRUITINGHuntersville, North Carolina, 28070, United States
-
Miami, Florida
RECRUITINGMiami, Florida, 33176, United States
-
Móstoles, Madrid
RECRUITINGMóstoles, Madrid, 28938, Spain
-
North Charleston, South Carolina
RECRUITINGNorth Charleston, South Carolina, 29406-9196, United States
-
Orlando, Florida
RECRUITINGOrlando, Florida, 32807, United States
-
Santa Ana, California
RECRUITINGSanta Ana, California, 92705, United States
-
Sterling Heights, Michigan
RECRUITINGSterling Heights, Michigan, 48314, United States
-
Stockbridge, GA
RECRUITINGAtlanta, Georgia, 30281, United States
-
Toronto
RECRUITINGToronto, Ontario, M5S 3A3, Canada
-
Verona
RECRUITINGVerona, VR, 37134, Italy
-
Willow Grove, Pennsylvania
RECRUITINGWillow Grove, Pennsylvania, 19090, United States
-
Winter Park, FL
RECRUITINGWinter Park, Florida, 32789, United States
-
Álava, Spain
RECRUITINGÁlava, 01004, Spain